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Abstract:  Here we present a new generic opto-bio-sensing platform combining immobilised 
aptamers on an infrared plasmonic sensing device generated by nano-structured thin film that 
demonstrates amongst the highest index spectral sensitivities of any optical fibre sensor yielding on 
average 3.4×104 nm/RIU in the aqueous index regime (with a Figure of Merit of 330) This offers a 
single stage, solution phase, atto-molar detection capability, whilst delivering real-time data for 
kinetic studies in water-based chemistry. The sensing platform is based upon optical fibre and has 
the potential to be multiplexed and used in remote sensing applications. As an example of the highly 
versatile capabilities of aptamer based detection using our platform, purified thrombin is detected 
down to 50 attomolar concentration using a volume of 1mm3 of solution without the use of any form 
of enhancement technique. Moreover, the device can detect nanomolar levels of thrombin in a flow 
cell, in the presence of 4.5% w/v albumin solution. These results are important, covering all 
concentrations in the human thrombin generation curve, including the problematic initial phase. 
Finally, selectivity is confirmed using complementary and non-complementary DNA sequences that 
yield performances similar to those obtained with thrombin.   
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1. Introduction  
Progress in biotechnology demands sensing platforms that can be readily combined with the specific 
and selective binding of target molecules by the inclusion of affinity reagents, such as aptamers, 
antibodies and other antibody mimetics. Aptamers (specific, single-stranded DNA oligonucleotides) 
are attractive affinity reagents and are potential antibody replacements for the development of 
biomolecular nanosensors owing to their high affinity, specificity, in-vitro synthesis and stability [1, 
2]. Aptamers are analogous to antibodies with respect to the variety of substances they can detect 
and their range of applications, but they have some distinct advantages [3]. One is their greater 
specificity and affinity [4], while others include their ability to tolerate a larger range of pH 
environments and temperature variations [3], with aptamers being more stable than antibodies. 
Moreover, aptamers have a greater shelf life than antibodies. The development of nucleic acid based 
aptamers and research into their potential applications has gathered pace since their inception in 1990 
[1]. These single-stranded short oligonucleotides form three-dimensional structures that bind to their 
target molecule with high affinity and specificity. As the oligonucleotides are short (15-60 bp) they 
can be routinely and reproducibly synthesised chemically.  The development of aptamers with 
affinity for a diverse range of biological targets has led to their employment not only in diagnostics 
but also in clinical/therapeutic [5] applications and as the affinity reagents in cell specific drug 
delivery [6]. 
 Of particular interest is the serine protease thrombin, which is crucial to clot formation and 
the blood coagulation process and is also important in anticoagulation, wound healing, chemotaxis 
and inflammatory responses [7]. Due to its important and diverse biological roles, thrombin was one 
of the initial targets for aptamer development [8]. As such, a wealth of literature characterizes not 
only the thrombin aptamer interaction, but also the use of such aptamers in thrombin quantification. 
Fibre optic evanescent wave sensors based upon fluorescent coagulation [9] and surface plasmon 
resonance (SPR) sensors [10-12], have been developed recently. These have been used to detect other 
biochemical compounds by utilising immobilized bio-recognition molecular coatings on a metallic 
surface. 
Surface plasmon resonance (SPR) is an important optical phenomenon that involves the resonant 
transfer of incident propagating light to surface-plasmon modes that take the form of collective 
electron oscillations in a metal [13]. Sensors exploiting SPR can be divided into three types based 
upon the kind of surface plasmon being generated at a metal/dielectric interface: long range surface 
plasmons (LRSP) [14], short range surface plasmons (SRSP) [15] and localised surface plasmons 
(LSP) [16]. SPR biosensors offer the opportunity for real-time and label-free monitoring of 
biomolecular interactions [17]. The plasmons exist at a metal–dielectric interface and depending on 
the topology of the supporting metal coating the dispersion relation can change [16]; the LRSP and 
SRSP obey the same dispersion relationship, whereas localised surface plasmons have a strong 
dependence on the surface structure [18]. 
We have previously reported some initial, modest experimental results of plasmonic fibre 
sensors [11] working in conjunction with aptamers that have shown potential as an optical chemical 
sensing platform.  SPR-based DNA sensing has previously achieved sensitivities down to femto and 
even atto-molar concentrations utilising enhancement amplification techniques [19-21], however 
these enhancement techniques at best complicate the binding mechanism with the inclusion of 
additional particles [22] and thus modify and compromise the binding kinetics.  
The authors here report for the first time an optical biosensing platform working with an 
immobilised aptamer that is able to detect attomolar concentrations of thrombin directly, without any 
further enhancement techniques (in a sample volume of 1mm3). The foundation upon which these 
results are based is an optical sensing platform utilizing surface plasmons resonances and offering 
spectral sensitivity to refractive index in excess of 3.4×104 nm/ RIU, leading to a conservative 
detection limit of 2.0×10-6 with a F.O.M. of 330 in the aqueous index regime for the sensing platform. 
This spectral index sensitivity is the highest reported in the literature [23-25] and leads to one of the 
highest index resolutions [23-25]. This result not only represents a 2 to 3 orders of magnitude 
improvement in detection limit over previous reports [26], but is also in the same range as those 
employing additional enhancement amplification techniques. The experimental data presented in this 
paper show the system is capable of monitoring in the solution phase and in real-time the binding of 
the aptamer to the target molecule without any additional species being involved, giving 
experimentalists the opportunity to study binding kinetics without the added complexity of an 
enhancement technique 
 
2. Fabrication and Characterisation of Bio-sensing Platform 
2.1 Optical Sensing Platform Fabrication 
For ease of interrogation an optical fibre platform was used for the devices, as has previously been 
described [27]. The devices were processed in three stages, resulting in a D-shaped fibre with nano-
structured multi-layered coatings. The multi-layered coatings consisted of three different materials: 
germanium (48nm), silicon dioxide (48nm) and gold (38nm). The nano-structuring consisted of 
surface corrugations with dominant structured spatial periods close to 0.5m, 1m, 2m and 4m, 
see schematic Fig. 1(a) and 1(b). 
  In brief, a lapped region of the fibre is coated sequentially with three materials; firstly 
germanium is deposited upon the lapped fibre followed by silicon dioxide and finally gold (Au-SiO2-
Ge/fibre). The nano-structuring of this coating is created by utilising the photobleaching effect that 
UV laser light has on germanium oxides, found in the multi-layered coating; the UV light produces 
a change in the optical properties (refractive index) and generates material compaction (a geometrical 
structural change [27]). This second effect is used to generate the nano-structure (array of nano-
wires) of the coating. The UV irradiance pattern is generated by a phase mask, producing a diffraction 
pattern that is conventionally used to produce fibre Bragg gratings. The UV irradiance is produced 
using an argon ion laser (Innova® Sabre® FRED) operating at 244nm. 
      Typical fabrication parameters used are a scanning velocity of 0.05mms-1 and a UV optical 
power on the fibre itself of approximately 120mW. The equipment and alignment used for producing 
conventional fibre Bragg gratings is used to create the nanostructured coated D-shaped fibres.  A 
typical period of a phase mask used in this process is 1.072 m and a typical surface topology created 
by this procedure is shown in Fig. 1(c) along with a schematic of the sensing evanescent field. The 
surface topologies have been characterised physically and chemically using an atomic force 
microscope (Park Scientific Instruments AutoProbe, Thermomicroscopes) (AFM) and X-ray 
Photoelectron Spectroscopy, (Thermo Fisher ESCALAB 250 Imaging XPS Instrument, spatial 
resolution 10nm) XPS. It was found that the resultant surface topology was characterised by regions 
having corrugation and the XPS revealed that the apexes of the surface ridges were metal surrounded 
by dielectric material. This creates an array of parallel nanowires perpendicular to the central axis of 
the optical fibre, see Figs. 1(c) and 1(d). The total length of the array depends upon the lapped region 
of the fibre, the length of the phase mask used and the scanning length of UV irradiance; typically 
the total length of the array is approximately 2.2cm. The nominal dimensions of a single corrugation 
are as follows: approximate length 20 m (perpendicular to the optical fibre central axis), with the 
individual apex of the corrugation having an average FWHM 180nm ± 20 nm. Fig. 1(e), shows a 
cross-section line profile for a few corrugations. Furthermore, closer inspection of Fig. 1(c) shows 
the UV processed region and pristine areas that are flat. Performing a Fast Fourier Transform on the 
AFM scan showed we have various spatial periods present with the predominant period being 
approximately half the phase mask period. The particular example yields periods of 0.512m and 
1.087m, see Fig. 1f. A higher resolution AFM scan revealed fine surface structures within a single 
nano-antenna, this appears to be due to the fact the phase mask produces a 3-dimensional interference 
pattern, see Fig. 1(d). These arrays support localised surface plasmons [27]. 
 
Fig. 1.  (a) Schematic representation of the multi-layered and nanoscale structured coating that supports the 
localised surface plasmons (b) Representation of the structured thin film coating created after the various stages of 
processing. (c) An example of an AFM image of the sensing region on the flat of the D-shaped fibre showing the 
surface corrugation after UV processing and a pristine surface. (d) An example of an AFM image showing the fine 
structure within several nano-antennas. (e) Typical experimental data of the height variation across several nano-
antennas. (f) A typical FFT of the cross-section along the nano-antenna array that is along the optical fibre axis and 
perpendicular to a single nano-antenna. 
 
 
The devices were characterised by measuring changes in their response as a function of the 
azimuthal polarisation properties of the illuminating light and of the surrounding medium’s refractive 
index. For the latter experiments, the fibres were placed in a V-groove and immersed in certified 
refractive index liquids that have a quoted accuracy of ± 0.0002, Fig.2(a). The V-groove was made 
in an aluminium plate, machined flat to minimise bending of the fibre. The plate was placed on an 
 (d)  (c) 
UV exposed material 
Pristine material 
optical table, which acted as a heat sink to help maintain a constant temperature throughout the 
experiments.  
2.2 Optical Detection Scheme 
Light from a broadband light source, was passed through a polariser and a polarisation controller 
before illuminating the sample, with the transmission spectrum being monitored using an optical 
spectrum analyser. The change in polarisation of the illuminating light was monitored with a 
polarimeter (Tektronix, PAT 9000B) through a polarisation maintaining coupler, see Fig.2(a). Due 
to the spectral broadness of the surface plasmon transmission features that are used to measure the 
concentration changes, the central wavelengths were calculated by using the first moment of the 
power spectrums; i.e. the centroid by geometric decomposition [28]. The associated transmission 
centroid strength value of the SPR was obtained as the mean value over the range where the extinction 
transmission feature is greater than 6dB level in attenuation. 
2.3 Aptamer Thrombin Assay Procedure 
Prepared fibres were coated with a thrombin aptamer 5’ – SH(CH2)6 - GGT TGG TGT GGT TGG 
- 3’ [29, 30].  The aptamer was immobilised to the fibre by a thiol mediated linkage. Fibres were 
stored in potassium phosphate buffer (100mM pH7.4).  Alpha thrombin from human plasma was 
obtained from Sigma (Sigma T6884). Binding buffer (50mM Tris 140mM NaCl 1mM MgCl2) pH 
7.4, was used for all binding experiments.  The BSA was supplied by Sigma-Aldrich product A9418 
2.4. Detection of Thrombin 
Thrombin solutions ranging from concentrations of 5aM to 1µM were prepared in a binding buffer 
by performing serial logarithmic dilutions on ice (to prevent de-naturation of the thrombin). The 
sensor was used in two different experiments; firstly, using a fixed volume of solution of thrombin, 
the sensor being exposed to the solutions lying in a flat aluminium v-groove. After each thrombin 
solution was used the v-groove and the sensors were washed in a 4 molar solution of NaCl to 
regenerate the sensors and further washed in 50 mM Tris binding buffer solution (pH 7.4). The 
apparatus used in these experiments are shown Fig.1a. The second experiment used a flow sample 
cell attached to a syringe driver to deliver a constant flow rate of a given solution, Fig. 2(b). Both 
sets of experiments consisted of two separate tests. The first was the detection of various 
concentrations of thrombin dissolved in buffer solution (50 mM Tris 140 mM NaCl 1 mM MgCl2) 
pH 7.4, using both a fixed volume and a flow sample cell used with a flow rate of 5 l/min. The 
second involved a repeat of these same experiments with the same concentrations of thrombin but in 
bovine serum albumin (BSA) at a concentration of 4.5% w/v, dissolved in a 50 mM Tris buffer 
solution (pH 7.4), which provides very similar test condition to samples from human beings. 
 
Fig. 2. Scheme used for the characterisation of the devices and the detection of the thrombin in ultra-low 
concentration solutions, (a) schematic of experimental apparatus used for fixed volumes of thrombin solutions and 
equipment to optimise the polarisation of the illuminating light to obtain a LSP resonance with maximum optical 
strength in the transmission spectrum, (b) image of the sample cell used for constant solution flow experiments. 
3. Experimental Results for Optical Sensing Platform and Biosensor   
 
3.1 Optical Sensing Platform Spectral Behaviour and Performance    
After the bare fibres are lapped, their spectral index and polarisation sensitivities are measured to 
ensure that the core of the fibre is not exposed and that there is enough optical dynamic range, so that 
the surface plasmon resonances in transmission can be fully measured. The highest refractive index 
solution used on the bare fibres is 1.448, because this is approximately the refractive index of the 
cladding, thus effectively removing the cladding/surrounding medium interface. Figures 3(a)-3(b) 
show a typical spectral index response and sensitivity of the bare D-shaped fibre. On inspection the 
individual spectra display a reasonably flat wavelength response with increasing index, up to the 
highest refractive index (1.448), displaying an average optical power loss of approximately 7 dB 
from air, with a device loss of ~1.8dB, see Fig. 3(b). The optical power losses as a function of 
polarisation were also investigated from an initial arbitrary polarisation state, this revealed that the 
average optical power varied by ±1 dB, see Fig. 3(c). Furthermore, there appears to be an asymmetric 
variation in the response to polarisation and this is due to the initial arbitrary starting-point.      
 
 
 
 
 
 
 
 
 
 
 
  
 
Fig.3. The spectral characterisation of the bare D-shaped fibre before coating and UV processing (a) the response 
of transmission spectra with increasing refractive index. (b) The average optical attenuation losses over the spectral 
range of 1250nm to 1690nm. (c) The variation of the average optical attenuation losses as a function of azimuthal 
polarisation measured from an initial, arbitrary polarisation state. 
 
 
 
After the array of nano-wires is produced on the D-shaped fibres and before the immobilisation of 
the thrombin aptamer, the spectral characteristics were again investigated with regard to changes in 
the refractive index of the surrounding medium and the light polarisation. A schematic of the 
apparatus to investigate the spectral behaviour is shown in Fig. 2(a) and described further in the 
method section 2. Fig.4(a) and Fig.4(b) shows the polarisation dependence of these devices and Fig.5 
shows the typical transmission spectral variation with changes in surrounding refractive index. 
 
 
 
 
 
 Fig. 4. The polarisation dependence of the optical sensing platform (Au-SiO2-Ge/fibre) before aptamer immobilisation: (a) 
an example of the spectral dependence upon polarisation (b) The Stokes parameters of the illuminating light of resonances 
across the spectral range of interest (c) the typical azimuthal polarisation dependence of a localised surface plasmon in air. 
Fig.4(a) illustrates that a single device can generate surface plasmon resonances of comparable 
strength over the available light source wavelength range, using all possible polarisation states of the 
illuminating light. For completeness of investigation we measured the degree of polarisation of the 
illuminating light used to produce the series of surface plasmon resonances over the spectral range 
of interest; 1280nm to 1690nm. The Stokes parameters were measured using an in-line polarimeter 
(General Photonics, Polarisation Analyser, POD-201) and the results are shown in Fig. 4(b). It was 
found that the percentage of the “Degree of Polarisation” varied linearly as a function of wavelength 
from 96.8% to 87.6% from the lower to higher wavelengths, respectively. The greatest variation 
occurring is with the azimuth of polarisation from 58.3 to 23.5 degrees, this doesn’t appear to be 
linear with spectral location of the resonance. The Stokes parameter S1 implies the light is linearly 
polarised, with both positive and negative values. These results are showing variations from 
horizontal to vertical linearly polarisation, which is expected due to the experimental set-up. The 
Stokes parameter S2 is varying from 0.7 to 0.9; S2 is associated with angled linearly polarised and S3 
has positive values which is associated with right-handed circularly polarised light. The S2 and S3 
parameters are suggesting different surface topological features are associated with the different 
transmission resonances.     
There are several reasons for this spectral tunability: the plasmons exist at a metal–dielectric 
interface and depending on the topology of the supporting metal coating the dispersion relation can 
change [16]; the LRSP and SRSP obey the following dispersion relation for two homogeneous semi-
infinite media: 
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where k is the free space wave number, m is the dielectric constant of the metal (m = mr+ i mi) and 
ns is the refractive index of the dielectric sample to be tested. A corrugated nano structure can be 
considered as an array of apertures [31], with the momentum component of light parallel  
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 to the surface, where p is a lattice constant (the distance between the apertures), 
i and j are nonzero integer numbers, representing the scattering orders from the two dimensional 
aperture arrays. The resonant condition for the localised surface plasmons that needs to be satisfied 
for a lattice structure is given by REF 18. From the FFTs of a typical UV processed surface shown 
in Fig. 1(c) and Fig. 1(d) there are a few potential lattice constants from primary structure of the 
nano-wire/nano-antenna array and from an individual nano-antenna. 
  The tunability is increased by the imperfections in the fabrication process (such as 
misalignment of the D-shaped fibre, the variations in the focusing of the UV light, variations in the 
alignment of the phase mask to the fibre and UV light intensity) causing a variation in the nanowires’ 
shapes, size, geometries and composition, which would yield a variation in the phase matching 
condition for the excitation of resonances and spectrally broaden the resonances and implies short 
propagation lengths [32], which are observed experimentally. Furthermore, the spectral features have 
large tunability and vary in coupling strength as a function of polarization and this indicates the 
presence of localized surface plasmons, instead of surface plasmons having short propagation lengths 
on rough surfaces that would produce reasonable resonance coupling over the azimuthal polarisation 
range from 0o to 180o. This fact along with the high polarisation sensitivity of 2.7dB/degree at the 
maximum strength of the excitation resonances shown in Fig.4(b), indicates that the optical sensing 
platform is generating localised surface plasmons (LSP). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. (a) The spectral transmission characteristics of the device (Au-SiO2-Ge/fibre) as a function of the index of 
the surrounding medium and (b) the spectral wavelength shift vs index. (c) The optical strength as a function of 
surrounding refractive index before aptamer immobilisation. (d) The transmission spectrum of the device after 
immobilisation of the thrombin aptamer when submerged in a buffer solution. 
 
 
Inspecting the results for the resonance wavelength dependence on surrounding index, Figs. 
5(a)-5(d) reveal a maximum bulk refractive index sensitivity of n of 1.7×104 nm/ RIU in the 
aqueous index regime, which yields a refractive index resolution of 5.9×10-6 and a Figure-of-Merit 
(FOM) of 210, determined using a standard approach [10, 17, 33-36] defined as FOM = 
(n)/FWHM, where FWHM is the full width at half maximum of the spectral feature. The index 
resolution is determined in part by the utilized interrogation scheme, which in this case is an optical 
spectrum analyser (OSA) that has 1000 measurable points over the FWHM of the resonance (80nm), 
leading to a measurement resolution of 0.08nm (greater than the resolution of the OSA). The peak 
resonance was measured over a 10 minute period yielding a variation of ±0.1nm. The FOM value for 
this sensing platform is reasonably good and has a typical mid-range value compared to other sensing 
systems [10, 17, 33-37]. The optical strength variation produced an index intensity sensitivity of 
n = 2.7×103 and yielded a resolution of 1.0×10-4 with a FOM of 97, which is less than was 
obtained for wavelength interrogation. Whilst the overall index sensitivity is very high the spectral 
features are relatively broad thus compromising the overall detection limit. The spectral sensitivities 
quoted above are typical of these devices, but there are variations. The spectral broadness of the 
surface plasmons and spectral characteristics are a function of the variation of the nanowires’ shapes, 
sizes and geometries, which can be improved and standardised through refining the fabrication 
technique. 
Fig.5(d) shows a typical transmission spectrum following immobilisation of the thrombin 
aptamer on the surface of the device when submerged in buffer solution. It is useful to estimate the 
index spectral sensitivity of the aptamer coated sensing platform for the reader to make comparisons. 
To achieve this, without compromising or corrupting the performance of the aptamer coated sensing 
platform with additional submersions into standard refractive index solutions, we used existing data 
from before the immobilisation of the thrombin aptamer, in particular the refractive index spectral 
sensitivity data given in Fig.5(b) that were obtained at the maximum excitation response for 
polarisation for each index solution. If we account for the measured maximised excitation of LSPR 
spectral location and assuming that the spectral sensitivity as a function of index continues with the 
same behavior at longer wavelengths, shown in Fig.5(b), it is estimated that the wavelength spectral 
sensitivity is approximately 3.4×104 nm/RIU, leading to a conservative detection limit of 2.0×10-6 
with a F.O.M. of 330 in the aqueous index regime for the sensing platform immobilised with the 
thrombin aptamer. These results are the highest index spectral sensitivities reported in the literature 
[23-25] and amongst the highest index resolutions [23-25]. 
 
3.2 Detection of thrombin 
Thrombin solutions ranging from concentrations of 5 aM to 1 µM were prepared on ice and then 
examined in two formats.  Purified thrombin was first assayed in static buffer solution in the 
apparatus illustrated in Figs. 1a and 1b, which demonstrated clear detection of thrombin down to 1 
nM concentration, Figs. 6(a) and 6(b). Thrombin was also detected within bovine serum albumin 
(BSA) at a concentration of 4.5% w/v dissolved in a 50 mM Tris buffer solution (pH 7.4), in a flow 
cell as illustrated in Fig. 2(b)c.  In this solution format, which aims to simulate human samples more 
closely, thrombin was detected at a 100 pM concentration. Moreover, in the flow-cell format, both 
association and dissociation of thrombin to the aptamer are visualized, Figs.6(c) and 6(d).  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Performance of the Au-SiO2-Ge/fibre coated aptamer device in the detection of thrombin. Parts (a) & (b) 
show wavelength shift and optical strength at the central wavelength responses respectively, in a fixed volume of 
static buffer, as a function of time, in response to thrombin concentrations over three orders of magnitude (1 nM  
1 µM) where thrombin was introduced at approximately 800 seconds. Parts (c) and (d) show similar results for two 
concentrations of thrombin in a flow cell with constant flow rate of 5 l/min, using a Tris Buffer solution with a 
thrombin concentration of 100 nM (─) and 100 pM (─), with injections of buffer / buffer/thrombin mix as 
indicated. 
Fig.6(a) shows the overall wavelength shift with a graphical axis break to show the finer 
detail of the wavelength variation as a result of the various concentrations of thrombin in the 50 mM 
Tris buffer solution (pH 7.4). Figure 6(b) shows the change in optical strength at the central 
wavelength of the SPR spectral feature: as the concentrations increase the overall power increases 
from a baseline of -4.8dB. We note that we neglected to include the initial optical strength of the 
plasmon resonance due to the fact we wanted to show clearly the changes in optical strength due to 
the differing concentrations of thrombin. Inspecting Fig. 6(a) it is noticeable that initial injections 
lead to a significant red-shift owing to the physical effects of mixing, however, once equilibrium has 
been reached, the greater the concentration of thrombin, the larger the blue-shift of the wavelength. 
This mixing effect can be seen in the transition period between the solutions with different 
concentrations. The change in optical strength of the resonance is more distinguishable than the 
wavelength changes, which prove to be relatively small. However, the latter are absolute 
measurements, whereas the optical strength can be corrupted by transient attenuation losses, such as 
fibre bending.  
Flow experiments were conducted with various concentrations of thrombin using flow rates 
of 5 l/min. Fig.6c and 6d illustrate typical association and dissociation of the thrombin (examples 
are 100 pM and 100nM) with aptamers immobilised on the surface of the optical sensor. 
We observe that with these devices the LSP resonances are tunable over a very large wavelength 
range, as shown in Fig.4(a). This also means the spectral characteristics (i.e. wavelength shift, 
spectral broadness and optical strength) and spectral sensitivity are very much dependent upon the 
spectral location of the LSP resonance through the material dependent dispersion characteristics [13, 
16, 23]. The dispersion relationship can result in blue or red wavelength shifts as a function of the 
surrounding refractive index and an increase or decrease in the optical strength of the resonance. This 
is illustrated in Fig.6, with Fig.6(a) and 6(b) having a resonance at a wavelength close to 1353nm 
and producing blue wavelength shifts with increasing concentration whilst Fig.6(c) and 6(d) have a 
resonance near 1423nm and produce a red wavelength shift.   
For the range of concentrations used there appears to be a demarcation from conventional 
equilibrium response with time at concentrations of about 100 pM and below. This can be seen in 
the association and dissociation time response curves shown in Figs. 6(c) and 6(d) with the lower 
concentration starting to show an unusual characteristic curve with additional smaller features 
appearing on the curves and what appears to be increasing variance at the steady state condition for 
this reaction. This behaviour is further illustrated in Fig. 7, showing the binding time response curve 
for a concentration of 50 aM.     
 The detection limit of these devices was then tested with a series of experiments with 
different sensors exposed to ultra-low concentrations of thrombin in 50 mM Tris buffer solution (pH 
7.4) - ranging from 5 aM to 1 pM concentrations in static format (Fig.1b). A summary of three typical 
sensors’ spectral response to various concentrations of thrombin are shown in Figs. 7(a) and 7(b). 
Meanwhile, the time response of one of the devices at one of the lower concentrations (50 aM) is 
shown in Figs. 7(c) and 7(d). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.7 Spectral sensitivity of aptamer-coated, static, multilayered SPR fibre devices (Au-SiO2-Ge/fibre). (a) Change 
in optical coupling strength as a function of thrombin concentration. (b) Magnitude of wavelength change as a 
function of thrombin concentration. In parts a & b, ●, ▲, and ■ represent measurements made with three different 
devices. (c) Wavelength change and (d) Change in optical strength as a function of time after submersion in a static 
cell containing 50 aM thrombin (e) Estimation of the settling/incubation times of the binding reaction as a function 
of thrombin concentration. 
There appears to be a log-linear relationship between thrombin concentration and both 
wavelength shift and change in optical strength Figs. 7(a) and 7(b), albeit that the correlation is 
closest between thrombin concentration and change in optical strength. These data sets demonstrate 
consistent behaviour of this sensing platform. Interestingly, the response times (estimated to be the 
time taken for the trend of the response of the system to settle) of these equilibriums for different 
concentration solutions do not have a linear relationship with concentration, Fig.7(e). Closer 
inspection of Fig. 7(e) shows that at approximately 100 pico-molar concentration there seems to be 
a change in the relationship of settling/incubation time to concentration, which is further explored in 
the discussion. However, the change in wavelength demonstrates greater resolution over the log-
linear range inasmuch as the response to attomolar solutions is clearly visible in terms of wavelength 
shift, Fig. 7(a), but barely discernable in terms of change in optical strength, Fig. 7(b).  Nevertheless, 
by adjusting the scale, binding between 50 aM thrombin and the immobilised aptamer is detectable 
by either measurement method, Figs. 7(c) and 7(d). This is particularly notable, since a concentration 
of 50 aM is equivalent to approximately 30 molecules of thrombin per µl of solution. 
 To assist in the understanding of the device, concentration-response curves are shown in 
Fig.8 for both change in wavelength and optical strength of the LSP resonance in the transmission 
spectra. We found that the devices had a saturation concentration of 36M and produced a maximum 
wavelength shift of 9.6nm and 3.2dB change in optical strength. The Hill coefficient for equilibrium 
was determined for both the optical strength change and wavelength shift using the standard graphical 
approach [37] and yields nHintensity = 0.229 and nHwavelength = 0.124, respectively, indicating negatively 
cooperative binding; once the target molecule is attached to the binding enzyme/chemical, the affinity 
for other target molecules decreases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8. The concentration-response curves of a (Au-SiO2-Ge/fibre) device based upon (a) wavelength shift and (b) 
optical strength change. 
 
 
Fig.8 yields half maximal effective concentration [38] (EC50) of 14 pMolar and 96 pMolar for 
wavelength and optical strength, respectively. There are several approaches to estimate the limit of 
detection of this sensing platform.  The detection limit can be estimated from the response with 
solutions at concentrations of 50aM and 5aM of thrombin in buffer; these two solutions produced 
wavelength shifts of 0.83nm and 0.43nm, respectively. There is a further complication associated 
with the measurement errors due to the increasing stochastic nature of the response of the system at 
these ultra-low concentrations, which can produce misleading results.  A second approach is to use 
the EC10 value to yield an estimate of detection [38] using EC𝐴 = (
𝐴
(100 − 𝐴)⁄ )
−𝑛𝐻
EC50, where A 
is the desired effective concentration and nH is the Hill coefficient (determined experimentally). Thus 
the EC10 point is 96aM and 68fM for wavelength and optical strength, respectively. We expect this 
difference due to the fact that the physical mechanism that governs the coupling strength to the 
surface plasmon is different to that involved in the phase matching condition [13, 15, 17, 22] leading 
to different concentration-response curves.  
Furthermore, another performance attribute of interest is the surface coverage resolution, 
which is the minimum identifiable valid change of molecular mass captured by the recognition 
molecule. The coverage can be defined [39] as 𝜎Γ =
𝜎𝑁ℎ
(Δ𝜆 Δ𝑛⁄ ) ∙ (
𝛥𝑛
Δ𝑐⁄ )
⁄  where N is the 
associated noise within the result (0.24nm), h is the thickness of the layer that has the refractive index 
change associated with the aptamer molecule (assumed here to be of the order of the size of the 
thrombin molecule, 5nm) and Δ𝑛 Δ𝑐⁄  is the volume refractive index increment of the molecular 
concentration, estimated to be about 0.18 cm3/g (DNA or BSA [39, 40]) leading to 0.2pg/mm2. This 
result again is amongst the highest from an optical sensing platform reported in the literature [22-25, 
41].    
Detection limits of the flow device were then examined. The binding flow experiments were 
performed using thrombin in 0.6 mM (4.5% w/v) bovine serum albumin (BSA) / 50 mM Tris-HCl 
pH 7.4.  As can be seen in Figs.9(a) and 9(b), BSA alone gave a consistent response both in terms of 
wavelength and optical strength, even after regeneration. However, detection of 10 nM thrombin in 
the presence of 4.5% (w/v) BSA is demonstrated far more clearly when examining wavelength shift, 
Fig. 9(a), circled in red, than when examining optical strength, Fig. 9(b), red circle. Higher sensitivity 
from observing wavelength shift is here more pronounced but nevertheless consistent with data 
observed in the static format, Fig.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. The spectral response of an SPR (Au-SiO2-Ge/fibre) device with an immobilised thrombin aptamer on its 
surface in the sample flow cell format, with a constant flow rate of 5l/min. Wavelength shift (a) and change in the 
optical strength (b) as a function of time. The sensor was initially washed with a 4.5% (w/v) BSA in Tris-HCl pH 
7.4, then regenerated with 4 M NaCl, followed by second BSA wash. Thrombin (10 nM) in a 4.5% (w/v) BSA in 
Tris-HCl pH 7.4 was introduced at 1800 s, which was followed by another regeneration in 4 M NaCl and a final 
BSA wash. 
 
One of the benefits of using an aptamer as the detecting molecule is that as single stranded DNA, it 
can also bind to its reverse complement. We therefore decided to examine both the specificity and 
sensitivity of the aptamer in the flow cell by examining the interaction with both complementary and 
non-complementary DNA sequences [30]. Fig. 10 demonstrates ready detection of complementary 
DNA at a 100 pM concentration, with no detectable signal generated by a non-complementary 
sequence of similar length. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Detection of hybridization between the DNA probe and both complementary and non-complementary 
single-stranded DNA sequences. The flow rate was 5 µl/min. The cell was first washed with buffer (300 mM NaCl, 
20 mM Na2HPO4, 0.1 mM EDTA, 0.05% TWEEN® 20, pH 7.4).  Non-complementary DNA was then introduced 
in the same buffer solution, followed by another buffer wash and then introduction of 100 pM complementary 
DNA, again in the same buffer. 
4. Discussion 
Inspecting all the experimental results including the examples shown in Figs. 4 and 5 over the range 
of concentrations used of thrombin and estimating their incubation times for each experiment, we 
observe times that are significantly smaller than the times predicted by conventional models based 
upon diffusion-limited capture for equilibrium reactions [40]. There is preceding literature that 
addresses this discrepancy [42-44]; the classical approach of modeling yields the mean incubation 
time, whilst experimental observations reveal the minimum detectable incubation time. It has been 
shown [43-45] for any sensor that the fundamental limit of detection for concentration under 
sufficiently long incubation times in a diffusion limited regime is given by a scaling relationship 
𝜌0𝑡𝑎𝑣𝑔
𝑀𝐷~𝑘𝐷, where tavg is the average or mean incubation time of the reaction, 0 is the initial 
concentration, MD and kD are sensor-dimensionality dependent constants. These two constants have 
been studied [42] for various surface morphologies and for a nanowire geometry MD  1 and 𝑘𝐷 =
𝑵𝒔𝒂𝟎
D
, where Ns is the minimum number of molecules needed to be captured for detection, D is the 
diffusion coefficient of the molecules and a0 is the radius of the nanowires which in our case is about 
30nm. Considering the conventional diffusion limit for an equilibrium, the diffusion coefficient can 
be calculated using the approach given in the literature [44]. We obtain a kD value of 8.110-10 leading 
to 8.1107 s for the average incubation time of the reaction with a concentration of 10 aM for a 
volume of 1mm3 (approximately 30000 molecules of thrombin), which is approaching 937 days.  
Furthermore, at approximately 100 pico-molar concentrations there appears to be a distinct 
demarcation between the conventional equilibrium kinetic behaviour and a more stochastic kinetic 
nature. This can be seen by making a comparison of the general temporal response of the binding 
reaction for solutions with thrombin concentrations of 100nM and 100pM shown in Figs. 6(c) and 
6(d). The response of the optical system to 100pM concentration solution starts to show fluctuations 
from a typical equilibrium time response, with more pronounced examples being shown in Figs. 7(c) 
and 7(d). This may be expected considering that the target thrombin molecule numbers are small in 
the volume of solution, and thus individual molecules can be considered to be acting independently 
from other thrombin molecules.  
Assuming that the red wavelength shift in Fig.6(a) is due to buffer ingression into the 
aptamer coating we can estimate the spectral and intensity sensitivity of the SPR device from 
Fig.6(b). By working to the intensity detection limit associated with this interrogation scheme 
(0.1dB) and using linear regression with the experimental data, the following empirical relationships 
for strength and wavelength change with concentration were obtained: dB= 0.26ln(Concen) + 
1.82 and nm= 0.83ln(Concen) + 7.15, where Concen is the molar concentration of thrombin. These 
formulae permit the estimation of a minimum detectable concentration of thrombin in the buffer 
solution, which is approximately 5 aM; this was confirmed using thrombin concentrations down to 
5aM, where no spectral changes were observed experimentally. The caveat here is that we are 
assuming the device has the same logarithmic spectral behaviour found at higher concentrations at 
the lower concentrations down to the limit of detection. 
Comparing these results with those given in reference 46 (detection limits in the order of 
1nM), this SPR device shows excellent detection sensitivity. Using the above data and the pseudo 
first-order kinetics approximation for the reaction of the aptamer and the thrombin, we estimated the 
association rate constant and the dissociation rate constant to be 1.06×106 ± 0.05×106 M-1s-1 and 
0.24±0.03 s-1 respectively, which leads to an equilibrium (association) constant of 4.28×106 ± 
0.07×106 M-1. These results compare well with the rate constant given in the literature [47-50] at 
similar concentrations. By comparison with our system, other approaches that make use of 
enhancement techniques may be compromised by the inclusion of additional particles to support the 
plasmons [22]. Similarly the approaches that make use of labelling also require the presence of 
additional species, e.g. fluorophores [1].  
The demonstration of thrombin detection in a 4.5% (w/v) BSA protein in binding buffer 
(50mM Tris 140mM NaCl 1mM MgCl2) pH 7.4, given in Fig.9 shows that BSA protein can be 
distinguished from the thrombin and that the thrombin has preferential interaction over the BSA. The 
authors do acknowledge that in real world applications using blood plasma there are a large number 
of other complex compounds and proteins present and nonspecific co-present binding cannot at this 
stage be ruled out. Nevertheless this particular test with 4.5% (w/v) BSA with thrombin is a step 
closer to the composition of blood, where the albumin (in humans it is human serum albumin) is the 
most common protein. Due to the concentration levels of the albumin protein it may adhere to the 
surface of the sensor and thus act as a blocker for the attachment of the thrombin to the aptamer. The 
detection limit of thrombin in the BSA solution was obtained by determining the experimentally 
observed wavelength shift as a function of thrombin concentration and using the spectral resolution 
of the resonance itself [33]; this yielded approximately 0.1nM, which is in the initial concentration 
range in the lag time of the typical human thrombin generation curve [51-56] (HTGC) resulting from 
samples taken from patients. Furthermore these sensing devices can also be used over the complete 
concentration range of a HTGC; at the peak thrombin level and through the endogenous thrombin 
potential [52-54].  
The average time interval between successive measurements varied for each experiment 
from 2 seconds to 6 seconds. The OSA covered an extended spectral range to observe as much of the 
transmission feature of the sensing platform as possible, up to approximately 400nm. The 
measurement time can be dramatically reduced to sub-second if required by reducing the spectral 
scanning range. The 3dB bandwidth of the localised surface plasmon excitation in the transmission 
spectrum varies from 80 nm to 200 nm (a typical transmission spectrum from a device is shown in 
Fig.5(d)). The interrogation scheme could be changed to other techniques that have higher data 
acquisition rates. For existing biosensing systems, the response time becomes excessively long for 
femtomolar and attomolar concentrations, ranging upwards from 300 seconds to as much as 105 
seconds [19]. Response time is important for a significant number of label-free clinical applications 
[29,46] and these times mean that the monitoring of real-time kinetics is not possible. The detection 
technique presented here yields continuous meaningful experimental data on an acquisition rate of 
approximately a second or less at femtomolar and attomolar concentrations and thus true binding 
kinetic data can be obtained.         
We can compare our performance against other thrombin sensing technologies, for example 
the Biacore system. That has a detection limit in concentration of around 10 pM [54], which is six 
orders of magnitude less sensitive than ours and yet has higher sensitivity compared to approaches 
such as electrochemical detection, where the detection limit is approximately 0.4nM [56], or other 
methods that employ a surface plasmon resonance, which yield 5nM [45]. Recently an SPR device 
with an enzymatic amplification approach [48] yielded a limit of 500 fM, this still represents several 
orders poorer resolution than the SPR device reported here. There are several approaches to the 
detection of thrombin with aptamers and most of these techniques have a limit of detection of 
approximately 1 to 10nM [49]; this again is significantly less sensitive. Secondly, comparing this 
scheme of detection to the conventional methods of measuring thrombin and associated coagulants: 
instruments with similar performance are financially expensive and not compatible with remote, real-
time operation. The presented scheme has the potential to be made relatively cheap and compact 
whilst still offering similar or better performance to the more conventional systems [55]. It must be 
stated that some of the detection schemes use small solution volumes, comparable to the volume used 
in this series of experiments, thus it’s reasonable to quote the total number of molecules/particles that 
are being detected, which is 30000. This may appear to be a large number compared to other schemes 
but a better comparison is the sensing coverage [34] for this particular molecule (thrombin), which 
is estimated be to 0.2pg/mm2 that is amongst the highest from an optical sensing platforms reported 
in the literature [23-25, 39].           
In conclusion, we have demonstrated a new opto-bio-sensing platform based upon aptamers 
immobilised onto an optical sensing structure that utilises infrared localised surface plasmons to 
provide a detection limit of a few attomolar concentrations of thrombin in a sodium phosphate buffer 
solution. This significantly outperforms other types of sensing platforms including fibre optic, 
surface plasmon or electrochemical thrombin sensors by four orders of magnitude. Our demonstrated 
approach offers advantages, for example the ability to evaluate variations in the picomolar range, 
which is inaccessible with classical techniques. In addition the performance of the device in the 
presence of non-specific protein provides an early indication that the sensitivity and specificity of 
the device may be maintained in a realistic environment. 
 Moreover, we may compare this optical sensing scheme to other fibre optical sensing 
methods, where the best reported performance to date is limited to detection levels of 500 fM  [48]. 
This limit of a few hundred fM has been echoed in a recent review paper [48].  Making a comparison 
to the other detection techniques [56, 57] the opto-bio-sensing platform offers the opportunity to 
collect real-time data for kinetic studies at ultra-low concentrations in the  femtomolar and attomolar 
ranges. The range of biological and chemical molecules for which high affinity aptamers have been 
developed is extensive and aptamer development continues apace. The successful employment of the 
well characterised 15 mer thrombin binding aptamer to our sensing device suggests our technology 
also has the potential to detect ultra-low concentrations of other chemicals, taking advantage of the 
so-called “lock-and-key” relationship between aptamers and their binding partners [49]. 
Furthermore, the chemical selectivity test was performed with another compound, a DNA probe, 
which provided evidence that this optical platform reflects the affinity of the binding molecule to the 
target molecule.    
The combination of this next generation localised surface plasmon sensing scheme with 
aptameric functionalised coatings offers great potential for remote sensing [55], providin as it does 
both high sensitivity and selectivity, coupled with a small physical footprint and low loss fibre 
connecting leads. In this regard the environmental application to remote sensing arrays for the 
detection of ultra-low concentrations of harmful substances is quite apparent. For example, our 
system has the potential to readily target estrogenic compounds, herbicides, pesticides, and industrial 
by-products that persist especially in the agricultural environment, which can cause infertility, 
deformed reproductive organs and other biological defects in extreme cases [50]. 
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